|
|
Volumn 4, Issue 4, 2002, Pages 319-325
|
|
Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
WARFARIN;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
REVIEW;
RISK;
TREATMENT OUTCOME;
ANTICOAGULANTS;
ASPIRIN;
CEREBROVASCULAR ACCIDENT;
DOUBLE-BLIND METHOD;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
ODDS RATIO;
PLATELET AGGREGATION INHIBITORS;
RANDOMIZED CONTROLLED TRIALS;
RECURRENCE;
TREATMENT OUTCOME;
WARFARIN;
MLCS;
MLOWN;
|
|
EID: 0347453426
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-002-0011-9 Document Type: Review |
|
Times cited : (12)
|
|
References (20)
|
